Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
RIGHTNOW TECHNOLOGIES INC (RNOW)
|
Add to portfolio |
|
|
|
| Price: |
$43.10
| | Metrics |
| OS: |
33.1
|
M
| |
33
|
% ROE
|
| Market cap: |
$1.43
|
B
| |
26
|
% ROIC
|
|
Net cash:
|
$66.5
|
M
| |
$2.01
|
per share
|
|
EV:
|
$1.36
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$23.0
|
M
| |
59.0
|
x EV/EBITDA
|
|
EBIT
|
$11.3
|
M
| |
120.1
|
x EV/EBIT
|
| EPS |
$0.77
| |
56.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| Revenues | 185.5 | 152.7 | 140.4 | 112.1 | 110.4 | 87.1 | 61.8 | 35.9 |
| Revenue growth | 21.5% | 8.7% | 25.3% | 1.5% | 26.7% | 41.1% | 72.1% | 33.2% |
| Cost of goods sold | 55.1 | 47.6 | 50.8 | 40.4 | 32.4 | 21.1 | 13.9 | 9.0 |
| Gross profit | 130.5 | 105.1 | 89.6 | 71.7 | 78.0 | 66.1 | 47.8 | 26.9 |
| Gross margin | 70.3% | 68.9% | 63.8% | 63.9% | 70.7% | 75.8% | 77.4% | 74.9% |
| Sales and marketing | 79.4 | 64.8 | 67.6 | 65.1 | 61.5 | 42.7 | 32.0 | 20.8 |
| Research and development | 20.2 | 20.2 | 18.3 | 17.1 | 14.5 | 10.4 | 7.8 | 5.9 |
| General and administrative | 18.7 | 15.8 | 13.6 | 11.5 | 9.6 | 6.4 | 4.6 | 3.5 |
| EBIT | 12.2 | 4.4 | -9.9 | -22.0 | -7.5 | 6.5 | 3.4 | -3.4 |
| EBIT margin | 6.6% | 2.9% | -7.1% | -19.7% | -6.8% | 7.5% | 5.5% | -9.4% |
| Pre-tax income | 12.6 | 6.5 | -7.2 | -18.4 | -4.5 | 8.2 | 3.5 | -3.6 |
| Income taxes | -15.8 | 0.6 | 0.0 | 0.3 | 0.5 | 0.5 | 0.1 | 0.5 |
| Tax rate | | 9.0% | | | | 5.8% | 2.8% | |
| Net income | 28.4 | 5.9 | -7.3 | -18.6 | -5.0 | 7.7 | 3.4 | -4.1 |
| Net margin | 15.3% | 3.8% | -5.2% | -16.6% | -4.5% | 8.8% | 5.6% | -11.5% |
| |
| Diluted EPS | $0.82 | $0.18 | ($0.22) | ($0.56) | ($0.15) | $0.23 | $0.12 | ($0.28) |
| Shares outstanding (diluted) | 34.6 | 32.3 | 33.4 | 33.1 | 32.3 | 33.7 | 29.2 | 14.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|